수의학용 단클론항체 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global monoclonal antibodies in veterinary health market size is expected to reach USD 9.93 Billion in 2034 from USD 1.99 Billion in 2025, growing at a CAGR of 19.59% during 2026-2034.The Global Monoclonal Antibodies in Veterinary Health Market is experiencing robust growth driven by rising pet ownership and increasing demand for advanced animal healthcare solutions. Monoclonal antibodies are gaining popularity for treating chronic conditions such as osteoarthritis and dermatological disorders in companion animals. Growing awareness among pet owners regarding specialized veterinary treatments is contributing significantly to market expansion.

Key drivers include technological advancements in biotechnology, increasing livestock disease prevalence, and a stronger focus on animal welfare. Pharmaceutical companies are investing heavily in research and development to create targeted biologics with improved safety profiles. Additionally, regulatory approvals for veterinary monoclonal antibody therapies are accelerating commercialization and expanding product portfolios across key regions.

In the coming years, innovation in antibody engineering and cost-effective manufacturing processes will strengthen market penetration. Emerging markets present significant untapped potential due to expanding veterinary healthcare infrastructure. As precision medicine gains momentum in animal health, monoclonal antibodies are expected to play a transformative role in improving treatment outcomes and supporting sustainable livestock production globally.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Application

• Dermatology
• Pain
• Others

By Animal Type

• Dogs
• Others

By End User

• Veterinary Hospitals
• Others

COMPANIES PROFILED

• Zoetis, Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, Virbac, Ceva Sante Animale, Dechra Pharmaceuticals, IDEXX Laboratories, PetMedix, Aratana Therapeutics, KindredBio, Invetx, Epitopix, Nextmune, VetStem, Anivive Lifesciences, Zoetis Diagnostics, Mars Veterinary Health, Heska, Vetoquinol

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type
• 5.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Animal Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Animal Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Animal Type
  • 7.4.3 By End User
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Animal Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Animal Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Zoetis
  • 9.2.2 Elanco Animal Health
  • 9.2.3 Boehringer Ingelheim Animal Health
  • 9.2.4 Merck Animal Health
  • 9.2.5 Virbac
  • 9.2.6 Ceva Sante Animale
  • 9.2.7 Dechra Pharmaceuticals
  • 9.2.8 IDEXX Laboratories
  • 9.2.9 PetMedix
  • 9.2.10 Aratana Therapeutics
  • 9.2.11 KindredBio
  • 9.2.12 Invetx
  • 9.2.13 Epitopix
  • 9.2.14 Nextmune
  • 9.2.15 VetStem
  • 9.2.16 Anivive Lifesciences
  • 9.2.17 Zoetis Diagnostics
  • 9.2.18 Mars Veterinary Health
  • 9.2.19 Heska
  • 9.2.20 Vetoquinol